Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-12-06 Purchase | 2024-02-06 1:10 pm | Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer | 2,500 | $0.782 | $1,955 | 8,918 (Direct) | View |
2022-06-06 Purchase | 2023-02-07 4:54 pm | Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer | 5,000 | $1.411 | $7,055 | 6,418 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-23 Option Award | 2024-07-24 5:26 pm | N/A 2034-07-22 | Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Operating Officer | 155,000 | $0 | 155,000 (Direct) | View |
2024-03-04 Option Award | 2024-03-06 1:29 pm | N/A 2034-03-03 | Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer | 235,000 | $0 | 235,000 (Direct) | View |
2023-02-27 Option Award | 2023-02-28 4:31 pm | N/A 2033-02-26 | Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer | 228,000 | $0 | 228,000 (Direct) | View |
2022-02-18 Option Award | 2022-02-23 9:22 pm | N/A 2032-02-17 | Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer | 190,000 | $0 | 190,000 (Direct) | View |
2021-02-04 Option Award | 2021-02-08 5:09 pm | N/A 2031-02-03 | Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2021-02-04 5:49 pm | N/A 2027-01-17 | Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer | 0 | $0 | 262,724 (Direct) | View |